Valneva SE

Valneva SE

Valneva SE

Valneva is a fully integrated vaccine company developing, manufacturing and commercializing innovative vaccines to protect people against infectious diseases.
Founded
1999
Raised
$27.8M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€25,000,000
Debt financing - 2016
European Investment Bank (EIB)
Team Size
1–10
Employees
Location
Headquarters
Pulse 2.0

Valneva SE (VALN) Stock: Why The Price Increased Today

€25,000,000 Debt financing
fiercepharma

Valneva nets €25M loan to fund vax pipeline work

Health Funding